Phase 1 Start~month

Phase 1 Start: An Open-label, Two-part Trial to Assess the Mass-balance Recovery, Metabolite Profile, Metabolite Id

Indication
Fibrostenotic Crohn's Disease

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 1 Start: An Open-label, Two-part Trial to Assess the Mass-balance Recovery, Metabolite Profile, Metabolite Id — AGMB Phase 1 Start | BioSniper